8 days of olim shining their light on Israel: Marta Weinstock-Rosin

Dr. Marta Weinstock-Rosin is a professor emeritus at Hebrew University of Jerusalem’s School of Pharmacy-Institute for Drug Research,

December 17, 2017 10:18
1 minute read.
Prof. Marta Weinstock-Rosin

Prof. Marta Weinstock-Rosin. (photo credit: HEBREW UNIVERSITY)


Dear Reader,
As you can imagine, more people are reading The Jerusalem Post than ever before. Nevertheless, traditional business models are no longer sustainable and high-quality publications, like ours, are being forced to look for new ways to keep going. Unlike many other news organizations, we have not put up a paywall. We want to keep our journalism open and accessible and be able to keep providing you with news and analysis from the frontlines of Israel, the Middle East and the Jewish World.

As one of our loyal readers, we ask you to be our partner.

For $5 a month you will receive access to the following:

  • A user experience almost completely free of ads
  • Access to our Premium Section
  • Content from the award-winning Jerusalem Report and our monthly magazine to learn Hebrew - Ivrit
  • A brand new ePaper featuring the daily newspaper as it appears in print in Israel

Help us grow and continue telling Israel’s story to the world.

Thank you,

Ronit Hasin-Hochman, CEO, Jerusalem Post Group
Yaakov Katz, Editor-in-Chief


Dr. Marta Weinstock-Rosin was the chief developer of Exelon, a drug that improves memory and slows its decline in those suffering from Alzheimer’s or Parkinson’s diseases.

Exelon is one of the most important drugs to have emerged from Israeli medical research in recent years, and Weinstock-Rosin’s achievement earned her the Israel Prize (the state’s highest cultural honor) for medicine in 2014. She also received the honor of lighting one of the 12 ceremonial torches at Israel’s official Independence Day celebration in 2015.

Born in Austria in 1935, Weinstock-Rosin managed to evade the Nazis by fleeing that country with her family in 1939, shortly before the start of the Holocaust. She made aliyah in 1969 from the UK with her husband Prof. Arnold Rosin, a leading gerontologist who co-founded Melabev organization that helps victims of dementia and their families.

Weinstock-Rosin is a professor emeritus at Hebrew University of Jerusalem’s School of Pharmacy-Institute for Drug Research, while her husband is an emeritus professor of gerontology at Jerusalem’s Shaare Zedek Medical Center.

Exelon improves the function of nerve cells in the brain by working to prevent the breakdown of a chemical that is important for the processes of memory, thinking, and reasoning. The drug alleviates Alzheimer’s symptoms or temporarily slows down their progression in 40-70 percent of patients.

Over the 8 days of Hanukka, The Jerusalem Post and Nefesh B’Nefesh bring you 8 extraordinary Olim from North America and the UK that have shined their respective light on Israel and the Jewish people. Nefesh B’Nefesh, the main facilitator of Aliya from these areas, has brought over 50,000 Olim to Israel since the organizations’ founding 10 years ago. Its annual Sylvan Adams Nefesh B’Nefesh Bonei Zion Prize honors these Olim each year. To nominate exceptional Anglo Olim making a difference in Israel, please visit: http://www.nbn.org.il/bonei-zion/

Nefesh B'Nefesh: Aliya Down the Line | NBN (YouTube/Nefesh B'Nefesh)

Join Jerusalem Post Premium Plus now for just $5 and upgrade your experience with an ads-free website and exclusive content. Click here>>

Related Content

An El Al plane in Ben Gurion Airport
June 27, 2019
Russia reportedly interfered with air navigation in Israel


Cookie Settings